Biliary disease Clinical Trials

9 recruitingLast updated: May 13, 2026

There are 9 actively recruiting biliary disease clinical trials across 7 countries. Studies span Not Applicable, Phase 3. Top locations include Calgary, Alberta, Canada, Bologna, BO, Italy, Chicago, Illinois, United States. Updated daily from ClinicalTrials.gov.


Biliary disease Trials at a Glance

9 actively recruiting trials for biliary disease are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Calgary, Bologna, and Chicago. Lead sponsors running biliary disease studies include University of Calgary, IRCCS Azienda Ospedaliero-Universitaria di Bologna, and Beijing Tsinghua Chang Gung Hospital.

Browse biliary disease trials by phase

Treatments under study

About Biliary disease Clinical Trials

Looking for clinical trials for Biliary disease? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Biliary disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Biliary disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Optimizing the Evaluation and Management of Patients With Suspected Choledocholithiasis

CholedocholithiasisBiliary disease
University of Calgary2,000 enrolled1 locationNCT05141916
Recruiting

Calgary Registry for Advanced and Therapeutic Endoscopy

Pancreatic DiseasesBiliary disease
University of Calgary6,000 enrolled1 locationNCT04259580
Recruiting

Prediction Model for MINS After Major Hepatobiliary Surgery

Postoperative ComplicationsLiver NeoplasmMyocardial Injury After Noncardiac Surgery (MINS)+1 more
Beijing Tsinghua Chang Gung Hospital1,800 enrolled6 locationsNCT07335042
Recruiting

Time to Post-operative Recovery of Serum Albumin as a Predictor of Outcome in Major Hepato Pancreato Biliary Surgeries

Bile Duct DiseasesPancreas DiseaseHepatobiliary Disease
Institute of Liver and Biliary Sciences, India1,000 enrolled1 locationNCT07263061
Recruiting
Phase 3

Evaluating the Safety and Efficacy of Duloxetine in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis

Biliary disease
Tanta University44 enrolled1 locationNCT06860984
Recruiting
Not Applicable

Exalt Single-use Duodenoscope Vs Reusable Scope, a Randomized Controlled Trial

Biliary DiseasesPancreatic Duct Disorder
Rush University Medical Center100 enrolled1 locationNCT06895785
Recruiting
Not Applicable

Diagnosis and Percutaneous Treatment of Biliary Tract Diseases

Biliary StrictureBiliary DiseasesGallstone
IRCCS Azienda Ospedaliero-Universitaria di Bologna24 enrolled1 locationNCT06816615
Recruiting

Lipid Profile and Ultrasound Findings in Patients With Pancreaticobiliary Diseases

Lipid Profile and Ultrasound Findings in Patients With Pancreaticobiliary Diseases
Alaa Mohamed Mostafa200 enrolled1 locationNCT06402305
Recruiting

Evaluation of the "Hot Spaxus" Lumen Apposing Stent for EUS-guided drainage of pancreatic walled off necrosis

hepato-biliary diseasenecrotising pancreatitis
St Vincent's Hospital Melbourne20 enrolled6 locationsACTRN12621000140853